Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma

Int J Hematol. 2004 Jan;79(1):52-4. doi: 10.1007/BF02983534.

Abstract

We present a patient with stage III de novo diffuse large B-cell lymphoma. The lymphoma cells showed mature B-cell immunophenotype but lacked surface immunoglobulin (Ig) expression. Long-distance and long-distance inverse polymerase chain reaction assays to detect the oncogene/Ig gene rearrangement revealed that the cells carried 3 independent fusion genes, namely, c-MYC/Ig heavy chain gene (IgH), BCL2/IgH, and Ig lambda light chain gene/BCL6. Thus, the lymphoma cells concurrently carried t(8;14)(q24;q32), t(14;18)(q32;q21), and t(3;22)(q27;q11), which developed in association with class switching, V/D/J recombination, and somatic hypermutation, respectively. The lymphoma responded to chemoradiotherapy, and the patient has been well for 2 years, suggesting that multiple oncogene rearrangements may not necessarily be associated with poor clinical outcome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / administration & dosage
  • Chromosomes, Human / genetics
  • Chromosomes, Human / ultrastructure*
  • Chromosomes, Human, Pair 14 / genetics
  • Chromosomes, Human, Pair 14 / ultrastructure
  • Chromosomes, Human, Pair 18 / genetics
  • Chromosomes, Human, Pair 18 / ultrastructure
  • Chromosomes, Human, Pair 22 / genetics
  • Chromosomes, Human, Pair 22 / ultrastructure
  • Chromosomes, Human, Pair 3 / genetics
  • Chromosomes, Human, Pair 3 / ultrastructure
  • Chromosomes, Human, Pair 8 / genetics
  • Chromosomes, Human, Pair 8 / ultrastructure
  • Combined Modality Therapy
  • DNA-Binding Proteins / genetics*
  • Dexamethasone / administration & dosage
  • Etoposide / administration & dosage
  • Genes, bcl-2*
  • Genes, myc*
  • Humans
  • Ifosfamide / administration & dosage
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / radiotherapy
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / genetics*
  • Lymphoma, Large B-Cell, Diffuse / radiotherapy
  • Male
  • Middle Aged
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-bcl-6
  • Proto-Oncogenes*
  • Radiotherapy, Adjuvant
  • Remission Induction
  • Transcription Factors / genetics*
  • Translocation, Genetic*

Substances

  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-6
  • Transcription Factors
  • Etoposide
  • Dexamethasone
  • Carboplatin
  • Ifosfamide

Supplementary concepts

  • ICE protocol 2